QA: Nuvalent Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001861560_2022_Nuvalent_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001861560')"}

Graph

Absolute values for 0001861560, Nuvalent Inc.

  xvar xval
0 AssetsCurrent 290,628,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 3,196,000
4 LiabilitiesCurrent 8,787,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,258,000
9 ResearchAndDevelopmentExpense 35,559,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -521,000
13 remainder_ComprehensiveNetIncome -228,000
  yvar yval
0 Assets 293,824,000
1 Liabilities 8,787,000
2 Expenses 45,817,000
3 Revenues 0
4 StockholdersEquity 285,037,000
5 NetIncome -46,338,000
6 ComprehensiveNetIncome -46,452,000
7 BaseVar 174,588,500
8 EconomicCapitalRatio 2.93

Edgar->Model Mapping

Feature Distribution

Change over Time